Editas Medicine, Inc.

EDIT - CIK 0001650664

Market cap-

Rank-

SEC filings693

EDIT income statement (annual)

The table below shows Editas Medicine, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$40.52M	$32.31M	$78.12M	$19.71M	$25.54M	$90.73M
Cost of revenue	-	-	-	-	-	-
Gross profit	-	-	-	-	-	-
R&D	$89.95M	$199.25M	$177.65M	$174.96M	$142.51M	$158.00M
SG&A

EDIT annual revenue (10-K history)

Editas Medicine, Inc. reported annual revenue of $40.52M for fiscal year 2025. That is up 25.4% from $32.31M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $6.05M (FY 2016) to $40.52M. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.